Cargando…
Osteoporosis Therapy With Denosumab in Organ Transplant Recipients
OBJECTIVE: Osteoporosis and fragility fractures represent serious complications for the solid organ transplant population. The recommended osteoporosis therapy for organ recipients involves supplementation with calcium and vitamin D and bisphosphonate administration. However, these options can prove...
Autores principales: | Brunova, Jana, Kratochvilova, Simona, Stepankova, Jitka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915642/ https://www.ncbi.nlm.nih.gov/pubmed/29720961 http://dx.doi.org/10.3389/fendo.2018.00162 |
Ejemplares similares
-
Retrospective Analysis of Bone Metabolism in Patients on Waiting List for Simultaneous Pancreas-Kidney Transplantation
por: Kratochvílová, Simona, et al.
Publicado: (2019) -
Does the VDR gene polymorphism influence the efficacy of denosumab therapy in postmenopausal osteoporosis?
por: Wawrzyniak, Anna, et al.
Publicado: (2023) -
Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment
por: Hirooka, Yasuaki, et al.
Publicado: (2021) -
Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
por: Hu, Mingwei, et al.
Publicado: (2023) -
Denosumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2017)